JP2013512676A5 - - Google Patents

Download PDF

Info

Publication number
JP2013512676A5
JP2013512676A5 JP2012542230A JP2012542230A JP2013512676A5 JP 2013512676 A5 JP2013512676 A5 JP 2013512676A5 JP 2012542230 A JP2012542230 A JP 2012542230A JP 2012542230 A JP2012542230 A JP 2012542230A JP 2013512676 A5 JP2013512676 A5 JP 2013512676A5
Authority
JP
Japan
Prior art keywords
scf
tpo
medium
pluripotent stem
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012542230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013512676A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/058990 external-priority patent/WO2011069127A1/en
Publication of JP2013512676A publication Critical patent/JP2013512676A/ja
Publication of JP2013512676A5 publication Critical patent/JP2013512676A5/ja
Pending legal-status Critical Current

Links

JP2012542230A 2009-12-04 2010-12-03 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成 Pending JP2013512676A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26693909P 2009-12-04 2009-12-04
US61/266,939 2009-12-04
US38416510P 2010-09-17 2010-09-17
US61/384,165 2010-09-17
PCT/US2010/058990 WO2011069127A1 (en) 2009-12-04 2010-12-03 Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016086761A Division JP2016135138A (ja) 2009-12-04 2016-04-25 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成

Publications (2)

Publication Number Publication Date
JP2013512676A JP2013512676A (ja) 2013-04-18
JP2013512676A5 true JP2013512676A5 (enExample) 2014-01-16

Family

ID=44115332

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012542230A Pending JP2013512676A (ja) 2009-12-04 2010-12-03 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成
JP2016086761A Pending JP2016135138A (ja) 2009-12-04 2016-04-25 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成
JP2019039160A Pending JP2019122385A (ja) 2009-12-04 2019-03-05 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成
JP2022011675A Pending JP2022064953A (ja) 2009-12-04 2022-01-28 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016086761A Pending JP2016135138A (ja) 2009-12-04 2016-04-25 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成
JP2019039160A Pending JP2019122385A (ja) 2009-12-04 2019-03-05 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成
JP2022011675A Pending JP2022064953A (ja) 2009-12-04 2022-01-28 無間質条件下におけるヒト胚性幹細胞からの機能的巨核球および血小板の大規模生成

Country Status (10)

Country Link
US (2) US9988603B2 (enExample)
EP (1) EP2507359A4 (enExample)
JP (4) JP2013512676A (enExample)
KR (4) KR20190142424A (enExample)
AU (4) AU2010325811A1 (enExample)
BR (1) BR112012013497A2 (enExample)
CA (2) CA2782013C (enExample)
IN (1) IN2012DN05054A (enExample)
RU (1) RU2012127810A (enExample)
WO (1) WO2011069127A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3712258B1 (en) 2006-04-14 2025-01-01 Astellas Institute for Regenerative Medicine Hemangio-colony forming cells
KR20190142424A (ko) 2009-12-04 2019-12-26 스템 셀 앤드 리제너러티브 메디신 인터내셔날, 인크. 기질 없는 조건 하에서 인간 배아줄기세포로부터 기능적 거핵구 및 혈소판의 대규모 생성
KR102108245B1 (ko) 2011-11-30 2020-05-08 아스텔라스 인스티튜트 포 리제너러티브 메디슨 중간엽 간질 세포 및 이에 관련된 용도
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
CN104471059B (zh) 2012-07-12 2018-04-17 珠海横琴爱姆斯坦生物科技有限公司 人胚胎干细胞衍生的间充质样干细胞、方法及其应用
US9074186B2 (en) 2012-08-15 2015-07-07 Boston Medical Center Corporation Production of red blood cells and platelets from stem cells
EP3973967A1 (en) * 2012-12-21 2022-03-30 Astellas Institute for Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
JP6580329B2 (ja) 2014-03-31 2019-09-25 シスメックス株式会社 未分化細胞から分化細胞および/または分化細胞の産生物を取得する方法
WO2015179301A1 (en) 2014-05-19 2015-11-26 Eleftherios Papoutsakis Megakaryocytic particles and microparticles for cell therapy & fate modification of stem and progenitor cells
AU2016242823A1 (en) * 2015-03-30 2017-09-21 Jeffrey Thomas Loh Methods for producing modified red blood cell compositions, compositions and uses thereof
AU2016308818B2 (en) 2015-08-18 2022-04-21 Astellas Institute For Regenerative Medicine Clinical formulations
CN108135940B (zh) * 2015-10-14 2022-04-15 株式会社美加细胞 纯化血小板的制造方法
MX2020007071A (es) 2018-01-05 2020-11-11 Platelet Biogenesis Inc Composiciones y metodos para producir megacariocitos.
WO2020006539A1 (en) 2018-06-29 2020-01-02 Platelet Biogenesis, Inc. Compositions for drug delivery and methods of use thereof
CA3178268A1 (en) 2020-05-11 2021-11-18 Jonathan Thon Compositions and methods related to megakaryocyte-derived extracellular vesicles

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128259A (en) 1989-10-27 1992-07-07 Hahnemann University Factor-dependent hematopoietic cell line exhibiting epo-induced erythrocyte maturation
EP1364197B1 (en) * 2001-01-29 2010-04-14 Ivan N. Rich ATP-based assay for the determination of the proliferation status of hematopoietic stem and progenitor cells
WO2002078449A2 (en) 2001-04-02 2002-10-10 Advanced Cell Technology, Inc. Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
WO2003046141A2 (en) 2001-11-26 2003-06-05 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
US20040052771A1 (en) 2002-07-12 2004-03-18 Lim Sai Kiang Hemangioblast progenitor cells
US20040229350A1 (en) 2003-05-12 2004-11-18 Nikolai Strelchenko Morula derived embryonic stem cells
CN1286970C (zh) 2003-12-30 2006-11-29 上海伯瑞生物技术发展有限公司 由脐血cd34+细胞体外诱导生成巨核细胞的方法
EP1735429A4 (en) 2004-03-31 2008-06-11 Newlink Genetics Corp METHOD AND COMPOSITIONS FOR OBTAINING EMBRYONAL STEM CELLS OF ABSTINENT HEMATOPOETIC STEM CELLS AND USES THEREOF
WO2006050330A2 (en) * 2004-11-01 2006-05-11 Wisconsin Alumni Research Foundation Platelets from stem cells
US7893315B2 (en) 2004-11-04 2011-02-22 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
WO2007095064A2 (en) 2006-02-09 2007-08-23 Wisconsin Alumni Research Foundation ERYTHROID CELLS PRODUCING ADULT-TYPE β-HEMOGLOBIN GENERATED FROM HUMAN EMBRYONIC STEM CELLS
CN101045914A (zh) 2006-03-29 2007-10-03 中国人民解放军军事医学科学院野战输血研究所 体外诱导造血干/祖细胞分化为成熟红细胞的方法与应用
EP3712258B1 (en) * 2006-04-14 2025-01-01 Astellas Institute for Regenerative Medicine Hemangio-colony forming cells
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9683232B2 (en) * 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
EP3441462A1 (en) 2008-05-06 2019-02-13 Astellas Institute for Regenerative Medicine Hemangio colony forming cells and non-engrafting hemangio cells
CN112280739A (zh) 2008-05-06 2021-01-29 安斯泰来再生医药协会 用于制备衍生自多能干细胞的去核类红细胞的方法
KR20190142424A (ko) 2009-12-04 2019-12-26 스템 셀 앤드 리제너러티브 메디신 인터내셔날, 인크. 기질 없는 조건 하에서 인간 배아줄기세포로부터 기능적 거핵구 및 혈소판의 대규모 생성

Similar Documents

Publication Publication Date Title
JP2013512676A5 (enExample)
US20220228118A1 (en) Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions
Choi et al. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures
US10724002B2 (en) Erythroid cells producing adult-type beta-hemoglobin generated from human embryonic stem cells
US9260696B2 (en) Method for developing natural killer cells from stem cells
CN111235105A (zh) 一种从人多能干细胞分化为自然杀伤细胞的方法及应用
KR20210003301A (ko) 다능성 줄기세포로부터 유도된 탈핵 적혈구계 세포를 생산하는 방법
JP2015519890A5 (enExample)
RU2012127810A (ru) Крупномасштабное получение функциональных мегакариоцитов и тромбоцитов из человеческих эмбриональных стволовых клеток в бесстромальных условиях
CN102329769A (zh) 一种获得造血干细胞的方法
EP4095240A1 (en) Serum-free medium and culturing method suited for culturing blood cells such as human hematopoietic stem cells
WO2025077136A1 (zh) 一种制备自然杀伤细胞的方法
Philonenko et al. Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines
Cerdan et al. Hematopoietic Differentiation
Fridley et al. Stem Cells and Hematopoiesis
HK40017506A (en) Method for developing natural killer cells from stem cells
HK1218927B (en) Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions